CMAH_HUMAN
ID CMAH_HUMAN Reviewed; 501 AA.
AC Q9Y471; C1K3L2; O95250; Q5TD41; Q5TD42; Q5TD43; Q5TD44; Q68DC3; Q9UEE7;
DT 10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT 29-APR-2015, sequence version 4.
DT 03-AUG-2022, entry version 131.
DE RecName: Full=Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase {ECO:0000305|PubMed:9751737};
DE Short=CMP-NeuAc hydroxylase-like protein;
DE AltName: Full=Cytidine monophosphate-N-acetylneuraminic acid hydroxylase pseudogene;
GN Name=CMAHP; Synonyms=CMAH;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND LACK OF ENZYME ACTIVITY.
RX PubMed=9751737; DOI=10.1073/pnas.95.20.11751;
RA Chou H.-H., Takematsu H., Diaz S., Iber J., Nickerson E., Wright K.L.,
RA Muchmore E.A., Nelson D.L., Warren S.T., Varki A.;
RT "A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-
RT Pan divergence.";
RL Proc. Natl. Acad. Sci. U.S.A. 95:11751-11756(1998).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, LACK OF ENZYME ACTIVITY,
RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX PubMed=19890979; DOI=10.1002/stem.250;
RA Nystedt J., Anderson H., Hirvonen T., Impola U., Jaatinen T., Heiskanen A.,
RA Blomqvist M., Satomaa T., Natunen J., Saarinen J., Lehenkari P., Valmu L.,
RA Laine J.;
RT "Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker
RT linked to stem cell-specific mechanisms.";
RL Stem Cells 28:258-267(2010).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=14574404; DOI=10.1038/nature02055;
RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA Rogers J., Beck S.;
RT "The DNA sequence and analysis of human chromosome 6.";
RL Nature 425:805-811(2003).
RN [4]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), LACK OF ENZYME
RP ACTIVITY, AND TISSUE SPECIFICITY.
RX PubMed=9624188; DOI=10.1074/jbc.273.25.15866;
RA Irie A., Koyama S., Kozutsumi Y., Kawasaki T., Suzuki A.;
RT "The molecular basis for the absence of N-glycolylneuraminic acid in
RT humans.";
RL J. Biol. Chem. 273:15866-15871(1998).
RN [5]
RP ENZYME INACTIVATION.
RX PubMed=11562455; DOI=10.1073/pnas.191268198;
RA Hayakawa T., Satta Y., Gagneux P., Varki A., Takahata N.;
RT "Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid
RT hydroxylase gene.";
RL Proc. Natl. Acad. Sci. U.S.A. 98:11399-11404(2001).
RN [6]
RP ENZYME INACTIVATION.
RX PubMed=12192086; DOI=10.1073/pnas.182257399;
RA Chou H.-H., Hayakawa T., Diaz S., Krings M., Indriati E., Leakey M.,
RA Paabo S., Satta Y., Takahata N., Varki A.;
RT "Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to
RT brain expansion during human evolution.";
RL Proc. Natl. Acad. Sci. U.S.A. 99:11736-11741(2002).
CC -!- FUNCTION: Sialic acids are components of carbohydrate chains of
CC glycoconjugates and are involved in cell-cell recognition and cell-
CC pathogen interactions. That protein has no CMP-N-acetylneuraminate
CC monooxygenase activity and is not able to convert CMP-N-
CC acetylneuraminic acid (CMP-Neu5Ac) into its hydroxylated derivative
CC CMP-N-glycolylneuraminic acid (CMP-Neu5Gc), a sialic acid abundantly
CC expressed at the surface of many cells in vertebrates (PubMed:9624188).
CC However, it may play a role in Wnt signaling (PubMed:19890979).
CC {ECO:0000269|PubMed:19890979, ECO:0000269|PubMed:9624188,
CC ECO:0000303|PubMed:11562455, ECO:0000303|PubMed:12192086,
CC ECO:0000303|PubMed:9751737}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19890979}. Note=May
CC localize to membranes, nucleus and cytoskeleton.
CC {ECO:0000269|PubMed:19890979}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=2;
CC Name=1;
CC IsoId=Q9Y471-1; Sequence=Displayed;
CC Name=2;
CC IsoId=Q9Y471-4; Sequence=VSP_057565, VSP_057566;
CC -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in thymus. Not
CC expressed in brain. May be expressed in adult stem cells (at protein
CC level) (PubMed:19890979). {ECO:0000269|PubMed:19890979,
CC ECO:0000269|PubMed:9624188}.
CC -!- SIMILARITY: Belongs to the CMP-Neu5Ac hydroxylase family.
CC {ECO:0000305}.
CC -!- CAUTION: An Alu-mediated mutation of this gene occured in a common
CC ancestor of Homo sapiens and Homo sapiens neanderthalis, approximately
CC 2.1-2.2 million years ago, before brain expansion. It is generally
CC accepted that the product of this gene, if any, is catalytically
CC inactive as suggested by the absence of CMP-Neu5Gc sialic acid in
CC human, while it is abundantly expressed at the surface of many cells in
CC other vertebrates. The gene is however, significantly transcribed and
CC the product described here might be expressed in vivo
CC (PubMed:19890979). The putative protein is N-terminally truncated
CC compared to orthologs and lacks a region probably essential to the CMP-
CC N-acetylneuraminate monooxygenase activity.
CC {ECO:0000269|PubMed:19890979, ECO:0000305|PubMed:11562455,
CC ECO:0000305|PubMed:12192086, ECO:0000305|PubMed:9624188,
CC ECO:0000305|PubMed:9751737}.
CC -!- SEQUENCE CAUTION:
CC Sequence=AAC68881.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF074480; AAC68881.1; ALT_SEQ; mRNA.
DR EMBL; FJ794466; ACN93797.1; -; mRNA.
DR EMBL; AL133268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AB009668; BAA31198.1; -; Genomic_DNA.
DR EMBL; D86324; BAA31160.1; -; mRNA.
DR AlphaFoldDB; Q9Y471; -.
DR IntAct; Q9Y471; 1.
DR iPTMnet; Q9Y471; -.
DR PhosphoSitePlus; Q9Y471; -.
DR BioMuta; HGNC:2098; -.
DR DMDM; 223590237; -.
DR PaxDb; Q9Y471; -.
DR PRIDE; Q9Y471; -.
DR GeneCards; CMAHP; -.
DR HGNC; HGNC:2098; CMAHP.
DR MIM; 603209; gene.
DR neXtProt; NX_Q9Y471; -.
DR InParanoid; Q9Y471; -.
DR PhylomeDB; Q9Y471; -.
DR TreeFam; TF331273; -.
DR BRENDA; 1.14.18.2; 2681.
DR PathwayCommons; Q9Y471; -.
DR ChiTaRS; CMAHP; human.
DR Pharos; Q9Y471; Tdark.
DR PRO; PR:Q9Y471; -.
DR Proteomes; UP000005640; Unplaced.
DR RNAct; Q9Y471; protein.
DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR GO; GO:0030338; F:CMP-N-acetylneuraminate monooxygenase activity; IBA:GO_Central.
DR GO; GO:0046381; P:CMP-N-acetylneuraminate metabolic process; IBA:GO_Central.
DR GO; GO:0030111; P:regulation of Wnt signaling pathway; IMP:UniProtKB.
DR Gene3D; 3.60.15.10; -; 1.
DR InterPro; IPR027033; Cnh.
DR InterPro; IPR036866; RibonucZ/Hydroxyglut_hydro.
DR PANTHER; PTHR46522; PTHR46522; 1.
DR SUPFAM; SSF56281; SSF56281; 1.
DR PROSITE; PS51296; RIESKE; 1.
PE 1: Evidence at protein level;
KW Alternative splicing; Cytoplasm; Reference proteome.
FT CHAIN 1..501
FT /note="Inactive cytidine monophosphate-N-acetylneuraminic
FT acid hydroxylase"
FT /id="PRO_0000127801"
FT VAR_SEQ 478..486
FT /note="VILQFSTER -> AILQECKTT (in isoform 2)"
FT /id="VSP_057565"
FT VAR_SEQ 487..501
FT /note="Missing (in isoform 2)"
FT /id="VSP_057566"
FT CONFLICT 87
FT /note="I -> V (in Ref. 4; BAA31160)"
FT /evidence="ECO:0000305"
FT CONFLICT 181
FT /note="I -> T (in Ref. 4; BAA31160)"
FT /evidence="ECO:0000305"
FT CONFLICT 241
FT /note="R -> W (in Ref. 4; BAA31160)"
FT /evidence="ECO:0000305"
FT CONFLICT 310
FT /note="R -> P (in Ref. 4; BAA31160)"
FT /evidence="ECO:0000305"
FT CONFLICT 478
FT /note="V -> A (in Ref. 2; ACN93797 and 1; AAC68881)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 501 AA; 58380 MW; 7C340A121B5ACA4D CRC64;
MDENNGLLLL ELNPPNPWDL QPRSPEELAF GEVQITYLTH ACMDLKLGDK RMVFDPWLIG
PAFARGWWLL HEPPSDWLER LCQADLIYIS HLHSDHLSYP TLKKLAGRRP DIPIYVGNTE
RPVFWNLNQS GVQLTNINVV PFGIWQQVDK NLRFMILMDG VHPEMDTCII VEYKGHKILN
IVDCTRPNGG RLPMKVALMM SDFAGGASGF PMTFSGGKFT EEWKAQFIKT ERKKLLNYKA
RLVKNLQPRI YCPFAGYFVE SHPSDKYIKE TNTKNDPNEL NNLIKKNSDV ITWTPRPGAT
LDLGRMLKDR TDSKGIIEPP EGTKIYKDSW DFEPYLEILN AALGDEIFLH SSWIKEYFTW
AGFKDYNLVV RMIETDEDFN PFPGGYDYLV DFLDLSFPKE RPQREHPYEE IHSRVDVIRH
VVKNGLLWDE LYIGFQTRLQ RDPDIYHHLF WNHFQIKLPL TPPNWKSFLM CCEQNGPVIL
QFSTERTNEP NRNKFSVENK A
